SF3 B1

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:DNA
gptkbp:associated_with splicing factor
gptkbp:code gptkb:splicing_factor_3_B_subunit_1
gptkbp:discovered_by gptkb:Anthropology
gptkbp:genetic_studies gptkb:myelodysplastic_syndromes
gptkb:Oncology
gptkbp:has_disease_association gptkb:Oncology
gptkbp:has_function regulation of gene expression
gptkbp:has_role RNA splicing
gptkbp:has_variants gptkb:K700_E
R625 H
S34 F
https://www.w3.org/2000/01/rdf-schema#label SF3 B1
gptkbp:interacts_with gptkb:U2_sn_RNP
gptkbp:involved_in pre-m RNA processing
gptkbp:is_associated_with disease progression
genomic instability
tumorigenesis
chromosomal abnormalities
leukemogenesis
gptkbp:is_essential_for cell viability
gptkbp:is_examined_in clinical trials
therapeutic targets
biomarker potential
gptkbp:is_expressed_in gptkb:Cell
gptkb:embryonic_development
various tissues
hematopoietic cells
cancerous tissues
gptkbp:is_involved_in RNA metabolism
cell cycle regulation
cellular stress response
protein synthesis
alternative splicing
m RNA maturation
gptkbp:is_linked_to cell differentiation
tumor microenvironment
treatment outcomes
poor prognosis
treatment resistance
gptkbp:is_part_of gptkb:spliceosome
RNA splicing pathway
cellular machinery
nuclear speckles
RNA processing machinery
spliceosomal complex
gptkbp:is_regulated_by transcription factors
gptkbp:is_studied_for therapeutic implications
gptkbp:is_studied_in molecular biology
cancer research
gptkbp:is_targeted_at gptkb:gene_therapy
therapeutic agents
gptkbp:located_in human chromosome 2
gptkbp:orthologs other species
gptkbp:bfsParent gptkb:myelodysplastic_syndromes
gptkbp:bfsLayer 5